METTL3 and gastric cancer: Several studies have reported that progression of GC is promoted by m6A writers, for example, METTL3-mediated m6A modification of some mRNA (HDGF [24], SPHK2 [37], and MYC [38]), which ultimately promotes gastric cancer progression, thus, exhibiting a prognostic significance.